utahmedical8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): May 4, 2012


Commission File No. 001-12575


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of
(I.R.S. Employer
   incorporation or organization)
Identification No.)
   

7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:                                                      (801) 566-1200
 
 
 
 
 

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS


On May 4, 2012 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:

Elected Kevin L. Cornwell as a director of the Company:
For
2,723,871
Withheld
52,884
Broker Non-Votes
462,822
           
Elected Paul O. Richins as a director of the Company:
For
2,698,468
Withheld
78,287
Broker Non-Votes
462,822
           
Ratified the selection of Jones, Simkins P.C. as the Company’s independent public accounting firm for the year ended December 31, 2012:
For
3,228,160
Against
5,177
Abstentions
6,240
           
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
For
2,731,595
Against
30,854
Abstentions
14,306
           


 
 
 

SIGNATURES


Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
   
   
Date:  5/08/2012
By:    /s/ Kevin L. Cornwell
 
Kevin L. Cornwell
 
CEO